Skip to content

On-X Mitral Heart Valve with Standard Sewing Ring ONXM-31/33Recalls & reported problems

On-X Life Technologies, Inc. · The On-X® Prosthetic Heart Valve is a bileaflet mechanical heart valve, which consists of an orifice housing and two leaflets. The orifice inflow area has a flared inlet designed to reduce flow turbulence, and the outflow rim consists of leaflet guards designed to protect the leaflets while in the closed position. The leaflets rotate around tabs located within the inner circumference of the orifice ring. In the closed position, each leaflet forms a nominal angle of 40º relative to the plane of the orifice. In the open position, the plane of each leaflet forms a nominal angle of 90deg relative to the plane of the orifice. The leaflets have a travel arc of 50deg to the closed position. The orifice, or housing, is composed of a graphite substrate coated with On-X® Carbon, a pure unalloyed form of pyrolytic carbon. The leaflets consist of On-X® Carbon deposited on a graphite substrate, which is impregnated with 10 weight% tungsten to provide radiopacity. The sewing cuff is constructed of polytetrafluoroethylene (PTFE) fabric mounted on the orifice using titanium retaining rings and 5-0 suture material. This form of sewing cuff attachment to the orifice allows for rotation of the sewing cuff in situ during implantation. Orientation reference marks are provided on the sewing cuff for valve orientation. The On-X® Prosthetic Heart Valve is available in 3 aortic and 2 mitral sewing cuff configurations. Aortic configurations are available in sizes 19, 21, 23, 25, and 27/29 mm. The standard mitral cuff is available in sizes 23, 25, 27/29 and 31/33, while the Conform-X® mitral cuff is available in size 25/33 only. Further detail for the On-X prosthetic heart valve is described in the Summary of Safety and Effectiveness documents for the On-X heart valves: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037b.pdf (aortic), and http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037S001b.pdf (mitral). · Class 3 · Implant

All models of On-X Mitral Heart Valve with Standard Sewing Ring (3)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
9
Deaths reported
2
Injuries reported
7
Recalls naming it
0

Summary

The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 00851788001297), received between Sep 25, 2015 and Nov 24, 2025 — classified as 2 deaths, 7 injuries.

The most frequently reported specific device problem is “Break” (2 reports).

4 other recalls cover devices cleared under the same FDA submission (P000037); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Break2
  • Appropriate Device Problem Term/Code Not Available1
  • Detachment of Device or Device Component1
  • Obstruction of Flow1
  • Perivalvular Leak1

Patient problems

  • Death2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Congestive Heart Failure1
  • Corneal Pannus1
  • Embolism1
  • Endocarditis1
  • Foreign Body In Patient1
  • Heart Failure1

Recent adverse event reports

The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT A ON-X MITRAL VALVE WAS EXPLANTED.

    Patient problems: Endocarditis

    MAUDE report 23632400 ↗
  • InjuryJan 16, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORT FROM ARTIVION REPRESENTATIVE, THE ONLY INFORMATION I HAVE AT THIS TIME IS THAT AN ON-X MITRAL VALVE "FAILED". ADDITIONAL INFORMATION RECEIVED FROM THE ARTIVION REPRESENTATIVE PER THE HOSPITAL'S CHARGE NURSE: SHE SAID THE DOCTOR IS NOT INTERESTED AT DISCUSSING FURTHER WITH ME. SHE DID SAY THE DOCTOR DID ACKNOWLEDGE THE VALVE COULD HAVE BEEN PLACED AT THE WRONG ANGLE/POSITION OR A SUTURE COULD HAVE IMPEDED FREE MOVEMENT OF THE LEAFLETS. NO ADDITIONAL INFORMATION WILL BE PROVIDED BY ACCOUNT.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available

    MAUDE report 21171006 ↗
  • InjuryNov 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL EMAIL, "DURING THE ANNUAL ON-X CEP/CER CYCLE A POSTER PRESENTATION WAS FOUND ¿SUCCESSFUL THROMBOLYSIS IN A CASE OF ON-X MITRAL VALVE THROMBOSIS." THIS PUBLICATION REPORTS ON A CASE OF A 55-YEAR-OLD MALE WHO PRESENTED WITH PROGRESSIVE DYSPNEA AND ATRIAL TACHYCARDIA. THREE MONTHS PRIOR HE UNDERWENT A MV REPLACEMENT WITH A 31/33 ON-X VALVE FOR RHEUMATIC MITRAL STENOSIS. INR WAS 1.2 DESPITE BEING COMPLIANT WITH WARFARIN. TEE SHOWED SIGNIFICANT PROSTHETIC MV OBSTRUCTION AND THROMBOSIS WAS CONFIRMED BY FLUOROSCOPY AND TEE. SLOW-INFUSION, LOW-DOSE TPA WAS INITIATED HOWEVER HE DEVELOPED ACUTE DECOMPENSATION WITH NYHA IV SYMPTOMS AND WAS GIVEN A BOLUS OF TPA TO AVOID SURGERY. HIS CLINICAL STATUS IMPROVED SIGNIFICANTLY, AND A REPEAT TEE SHOWED RESOLVED MV OBSTRUCTION."

    Patient problems: Tachycardia; Thrombosis/Thrombus

    MAUDE report 20587251 ↗
  • DeathFeb 11, 2020Break; Detachment of Device or Device Component; Break; Detachment of Device or Device Component

    ACCORDING TO THE INITIAL REPORT, THE PATIENT WAS IMPLANTED WITH ONXM-31/33 IN THE MITRAL POSITION ON (B)(6) 2019. ON (B)(6) 2020 AN ECHOCARDIOGRAM SHOWED A LEAFLET WAS MISSING AND HAD MIGRATED. THIS RESULTED IN CARDIOGENIC SHOCK AND METABOLIC ACIDOSIS. THE SURGEON ATTEMPTED MITRAL VALVE REPLACEMENT, BUT WAS UNSUCCESSFUL. THE PATIENT DEVELOPED PROLONGED HYPERTENSION AND HYPO PERFUSION, FOLLOWED BY MULTI-ORGAN FAILURE. THE PATIENT DID NOT LIVE. RADIOGRAPHIC SCANS SHOW THE DISLODGED VALVE AT THE LEVEL OF THE L2 VERTEBRA. REFERENCE MEDWATCH REPORT MW5092348.

    Patient problems: Death

    MAUDE report 9694503 ↗
  • InjuryApr 3, 2018Perivalvular Leak; Perivalvular Leak

    ACCORDING TO REPORTS FROM THE PATIENT'S WIFE, "THEY REMOVED THE MECHANICAL VALVE AND REPLACED IT WITH A TISSUE VALVE." BASED ON INFORMATION OBTAINED FROM A PREVIOUS EVENT, THE EXPLANT WAS DUE TO PARAVALVULAR LEAK. PLEASE REFERENCE MANUFACTURER REPORT NUMBER 1649833-2018-00001 FOR PREVIOUSLY REPORTED EVENT .

    Patient problems: Congestive Heart Failure

    MAUDE report 7392990 ↗
  • InjuryDec 13, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INFORMATION RECEIVED, A (B)(6) MALE RECEIVED AN ONXM-31/33 ((B)(4)) ON (B)(6) 2017 AND REQUIRED RE-INTERVENTION/EXPLANT ON (B)(6) 2017 DUE TO SEVERE LARGE POSTERIOR DEHISCENCE OF PRIOR MITRAL PROSTHESIS. IT WAS REPLACED WITH AN ONXMC-25/33 VALVE.

    Patient problems: Heart Failure; Regurgitation

    MAUDE report 7112188 ↗
  • DeathApr 10, 2017Break; Break

    ACCORDING TO THE INITIAL EMAIL FROM THE DISTRIBUTOR, "I REPORT YOU THE ACCIDENT HAPPENED TODAY ABOUT LEAFLET'S ESCAPE. ONE LEAFLET OF MITRAL 31/33, WHICH IMPLANTED ON (B)(6) 2013 TO THE (B)(6) MALE, WAS ESCAPED AND TRAPPED AT KIDNEY ARTERY. PATIENT WAS OPERATED TODAY AND REPLACED TO BIOLOGICAL VALVE BUT ESCAPED LEAFLET HAS NOT YET TAKEN OUT. THE PATIENT CONDITION IS NOT SO WELL HE HAS BEEN UNDER PCPS SINCE YESTERDAY WHEN HE WAS DELIVERED AS EMERGENCY PATIENT." ADDITIONAL INFORMATION FROM ANOTHER REPRESENTATIVE AT (B)(6) INDICATED THE FOLLOWING: "WE HAVE RECEIVED A SERIOUS COMPLAINT REGARDING ON-X MITRAL VALVE FROM HOSPITAL SAYING THAT ONE SIDE OF THE LEAFLETS WAS TOLD TO BE COME OFF OR FRAGMENTED (STILL UNKNOWN) FROM THE VALVE HOUSING. CT SCANNED PICTURE TELLS THE DETACHED LEAFLET SEEMS TO BE STAYING NEAR RENAL ARTERY, BUT DOCTORS ARE STILL NOT SURE WHETHER FRAGMENTED PARTS (IF THERE ARE) IN OTHER PARTS OF THE BODY. THE PATIENT IS A MALE, WHO HAD MVR (ON-X M VALVE) AND TRICUSPID VALVE PLASTY AT THE SAME TIME IN 2013, BEING BROUGHT TO THE HOSPITAL DUE TO RESPIRATORY FAILURE WAS FINALLY FOUND TROUBLE WITH THE REPLACED MITRAL VALVE. A BIOLOGICAL VALVE WAS USED TO REPLACE THE TROUBLED

    Patient problems: Death; Embolism; Foreign Body In Patient

    MAUDE report 6475529 ↗
  • InjurySep 29, 2016Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available

    ACCORDING TO THE (B)(6), PATIENT IMPLANTED WITH ONXM 31/33 ON (B)(6) 2006 AND REQUIRED INTERVENTION/EXPLANT DUE TO "BIOPROSTHETIC MITRAL STENOSIS" ON (B)(6) 2016 AND WAS REPLACED WITH AN ONXMC-25/33.

    Patient problems: Mitral Valve Stenosis

    MAUDE report 5986527 ↗
  • InjurySep 25, 2015Obstruction of Flow

    EMAIL FROM SURGEON IN (B)(6) STATES HE HAD A PATIENT WITH AN OBSTRUCTION OF HIS ON-X VALVE IN THE TRICUSPID POSITION (AN OFF-LABEL USE OF THE ON-X VALVE, DONE AT THE SOLE DISCRETION OF THE SURGEON). THIS PATIENT HAD PREVIOUS MITRAL AND TRICUSPID REPLACEMENTS > 10 YEARS AGO, AND UNDER ANTICOAGULATION WITH DICUMAROL. THE REPORT ALLEGES THE PATIENT DEVELOPED PANNUS FORMATION ON THE TRICUSPID VALVE. THE SURGEON RE-OPERATED AND REPLACED THE ON-X VALVE IN THE TRICUSPID POSITION WITH A TISSUE VALVE. THE PATIENT IS DOING FINE. THE SURGEON WAS LOOKING FOR LITERATURE REFERENCES ON OBSTRUCTION W/ PANNUS OF A TRICUSPID VALVE. THE SURGEON WAS INFORMED THAT THERE HAVE BEEN NO CONFIRMED REPORTS OF PANNUS WITH THE ON-X HEART VALVES. ON-X INQUIRED AS TO AVAILABILITY OF THE VALVE FOR RETURN FOR INVESTIGATION, TO WHICH NO RESPONSE WAS RECEIVED. CURRENTLY WORKING WITH THE DISTRIBUTOR IN (B)(4) TO ATTEMPT GETTING THE VALVE BACK TO DETERMINE IF THE MATERIAL IS ACTUALLY PANNUS OR THROMBUS. IN 1 PAST PATHOLOGY INVESTIGATION, ALLEGED PANNUS WAS FOUND TO BE THROMBUS. IF FURTHER INFORMATION BECOMES AVAILABLE, A FOLLOW-UP REPORT WILL BE FILED. THIS IS BEING REPORTED BECAUSE IT WAS REQUIRED THAT THE PATIENT UN

    Patient problems: Corneal Pannus

    MAUDE report 5104311 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P000037. One submission often covers many models, so check the product and lot details in each record.

  • Z-2133-2026 · Feb 1, 2026 · Open, Classified
    On-X Mitral Heart Valve with Conform-X Sewing Ring, Model: ONXMC-25/33
  • Z-1073-2019 · Jan 17, 2019 · Terminated
    On-X Aortic Heart Valve with Anatomic Sewing Ring Product Usage: The On-X Prosthetic Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native
  • Z-2715-2017 · Jun 12, 2015 · Terminated
    On-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic and mitral positio
  • Z-3108-2017 · Feb 12, 2014 · Terminated
    On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in th

Other Heart-Valve, Mechanical devices

All Heart-Valve, Mechanical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page